Ingmar Skoog
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ingmar Skoog has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Kaj Blennow
2 shared publicationsSten Landahl
From the Institute of Clinical Neuroscience, Department of Psychiatry, Sahlgrenska University Hospital (I.S.), the Department of Geriatric Medicine, Vasa Hospital (S.L., B.L.), Göteborg University, and the Department of Radiology, Östra Hospital (L.-A.A.), Göteborg, Sweden
2 shared publicationsB Johansson
1 shared publicationBodil Lernfelt
From the Institute of Clinical Neuroscience, Department of Psychiatry, Sahlgrenska University Hospital (I.S.), the Department of Geriatric Medicine, Vasa Hospital (S.L., B.L.), Göteborg University, and the Department of Radiology, Östra Hospital (L.-A.A.), Göteborg, Sweden
1 shared publicationCamilla Hesse
1 shared publicationGunnar Skoog
Institute of Clinical Neuroscience, Department of Psychiatry, Sahlgrenska University Hospital, Göteborg University, Sweden
1 shared publication
Latest Publications
- 1 March 2000
- Vol. 101 (3) , 185-93
A population study on the influence of depression on neuropsychological functioning in 85-year-olds.
To examine cognitive function in very old depressed individuals. Individuals with major depression (MDS) or dysthymia according to the DSM-III-R were compared to mentally healthy regarding tests of verbal ability, inductive logical reasoning, spatial ability, perceptual speed, basic arithmetics, primary memory and secondary memory in a population-based sample of 85-year-olds. Individuals with MDS performed worse than mentally healthy individuals in tests of verbal ability, inductive logical reasoning, spatial ability, perceptual speed and secondary memory. There were no differences between the groups regarding basic arithmetics and primary memory. The poor test performance was mainly associated with psychomotor retardation and decreased concentration in depressed individuals. Memory complaints were not correlated to poor test performance, neither in the mentally healthy nor in the depressed. MDS in elderly individuals is associated with reduced cognitive test performance, especially regarding more complex and time-demanding tests and in tests of secondary memory.
- 1 March 2000
- Vol. 101 (3) , 185-93
A population study on the influence of depression on neuropsychological functioning in 85-year-olds.
To examine cognitive function in very old depressed individuals. Individuals with major depression (MDS) or dysthymia according to the DSM-III-R were compared to mentally healthy regarding tests of verbal ability, inductive logical reasoning, spatial ability, perceptual speed, basic arithmetics, primary memory and secondary memory in a population-based sample of 85-year-olds. Individuals with MDS performed worse than mentally healthy individuals in tests of verbal ability, inductive logical reasoning, spatial ability, perceptual speed and secondary memory. There were no differences between the groups regarding basic arithmetics and primary memory. The poor test performance was mainly associated with psychomotor retardation and decreased concentration in depressed individuals. Memory complaints were not correlated to poor test performance, neither in the mentally healthy nor in the depressed. MDS in elderly individuals is associated with reduced cognitive test performance, especially regarding more complex and time-demanding tests and in tests of secondary memory.
- 1 July 1999
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 12 (4) , 487-493
Genetic testing for Alzheimerʼs disease: how close is reality?
Three genes in which mutations cause the early-onset autosomal dominant form of Alzheimer's disease have been identified. These are the amyloid precursor protein gene on chromosome 21, the presenilin-1 gene on chromosome 14, and the presenilin-2 gene on chromosome 1. Mutations in any of these genes cause an enhanced production of the long form of β-amyloid. There is one established susceptibility gene, the apolipoprotein E gene, in which the ε4 allele causes an increased risk of developing Alzheimer's disease. Other potential susceptibility genes for Alzheimer's disease have also been identified, but their importance has to be further established. At present, genetic testing is only warranted in early-onset forms of Alzheimer's disease with a familial clustering. This testing needs strong ethical consideration. Testing for the apolipoprotein E genotype may aid in the clinical diagnosis of Alzheimer's disease, but should not be performed as a screening tool in nonsymptomatic patients.
- 1 July 1999
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 12 (4) , 487-493
Genetic testing for Alzheimerʼs disease: how close is reality?
Three genes in which mutations cause the early-onset autosomal dominant form of Alzheimer's disease have been identified. These are the amyloid precursor protein gene on chromosome 21, the presenilin-1 gene on chromosome 14, and the presenilin-2 gene on chromosome 1. Mutations in any of these genes cause an enhanced production of the long form of β-amyloid. There is one established susceptibility gene, the apolipoprotein E gene, in which the ε4 allele causes an increased risk of developing Alzheimer's disease. Other potential susceptibility genes for Alzheimer's disease have also been identified, but their importance has to be further established. At present, genetic testing is only warranted in early-onset forms of Alzheimer's disease with a familial clustering. This testing needs strong ethical consideration. Testing for the apolipoprotein E genotype may aid in the clinical diagnosis of Alzheimer's disease, but should not be performed as a screening tool in nonsymptomatic patients.
- 1 February 1999
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 56 (2) , 121-127
A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
Research from JAMA Psychiatry — A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
- 1 February 1999
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 56 (2) , 121-127
A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
Research from JAMA Psychiatry — A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
- 1 January 1999
- Published by Springer Nature
- p. 121-134
Possibilities for Secondary Prevention of Alzheimer’s Disease
- 1 January 1999
- Published by Springer Nature
- p. 121-134
Possibilities for Secondary Prevention of Alzheimer’s Disease
- 1 September 1998
- Published by Wolters Kluwer Health in Hypertension
- Vol. 32 (3) , 404-409
A Population-Based Study on Blood Pressure and Brain Atrophy in 85-Year-Olds
—In the general population, mean systolic and diastolic blood pressure increases up to age 75 years but decreases thereafter. The brain has a role in blood pressure regulation; it is not clear whether the cerebral changes that occur with aging contribute to the decline in blood pressure in the very elderly. We examined a population-based sample of 484 85-year-old persons (344 nondemented and 140 demented, 61 with Alzheimer’s disease, 65 with vascular dementia, and 14 with other types of dementia) with a neuropsychiatric examination and blood pressure measurements. Dementia was diagnosed according to the criteria proposed in the Diagnostic and Statistical Manual of Mental Disorders, edition 3, revised . Brain atrophy was measured by CT of the brain. In the nondemented group, frontal ( r =−0.18, P =0.037) and parietal ( r =−0.23, P =0.008) cortical atrophy and bifrontal ratio ( r =−0.20, P =0.013) were associated with lower systolic blood pressure, and frontal ( r =−0.23, P =0.010) and parietal ( r =−0.24, P =0.008) cortical atrophy and bifrontal ratio ( r =−0.23, P =0.006) with lower diastolic blood pressure. Systolic blood pressure was lower in subjects with Alzheimer’s disease and vascular dementia, and diastolic blood pressure was lower in those with vascular dementia compared with the nondemented. Systolic ( r =−0.27, P r =−0.10, P =0.020) blood pressure was negatively correlated to dementia severity. In the demented subjects, frontal cortical atrophy was correlated to lower diastolic blood pressure ( r =−0.21, P =0.043). Our findings suggest that age-related changes in brain structure may contribute to the decrease in blood pressure in the very elderly and that low blood pressure in dementia disorders is mainly a secondary phenomenon.
- 1 September 1998
- Published by Wolters Kluwer Health in Hypertension
- Vol. 32 (3) , 404-409
A Population-Based Study on Blood Pressure and Brain Atrophy in 85-Year-Olds
—In the general population, mean systolic and diastolic blood pressure increases up to age 75 years but decreases thereafter. The brain has a role in blood pressure regulation; it is not clear whether the cerebral changes that occur with aging contribute to the decline in blood pressure in the very elderly. We examined a population-based sample of 484 85-year-old persons (344 nondemented and 140 demented, 61 with Alzheimer’s disease, 65 with vascular dementia, and 14 with other types of dementia) with a neuropsychiatric examination and blood pressure measurements. Dementia was diagnosed according to the criteria proposed in the Diagnostic and Statistical Manual of Mental Disorders, edition 3, revised . Brain atrophy was measured by CT of the brain. In the nondemented group, frontal ( r =−0.18, P =0.037) and parietal ( r =−0.23, P =0.008) cortical atrophy and bifrontal ratio ( r =−0.20, P =0.013) were associated with lower systolic blood pressure, and frontal ( r =−0.23, P =0.010) and parietal ( r =−0.24, P =0.008) cortical atrophy and bifrontal ratio ( r =−0.23, P =0.006) with lower diastolic blood pressure. Systolic blood pressure was lower in subjects with Alzheimer’s disease and vascular dementia, and diastolic blood pressure was lower in those with vascular dementia compared with the nondemented. Systolic ( r =−0.27, P r =−0.10, P =0.020) blood pressure was negatively correlated to dementia severity. In the demented subjects, frontal cortical atrophy was correlated to lower diastolic blood pressure ( r =−0.21, P =0.043). Our findings suggest that age-related changes in brain structure may contribute to the decrease in blood pressure in the very elderly and that low blood pressure in dementia disorders is mainly a secondary phenomenon.
- 1 July 1998
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 9 (Suppl. 1) , 13-19
A Review on Blood Pressure and Ischaemic White Matter Lesions
Hypertension or high blood pressure is constantly reported to be the main risk factors for ischaemic white matter lesions (WMLs). These lesions show the histopathological picture of diffuse demyelination and moderate loss of axons in subcortical structures. The main hypothesis regarding the association between high blood pressure and ischaemic WMLs is that long-standing hypertension causes lipohyalinosis of the media and thickening of the vessel walls with narrowing of the lumen of the small perforating arteries and arterioles which nourish the deep white matter. Episodes of hypotension may then lead to hypoperfusion and hypoxia-ischaemia in the white matter. In line with this, low blood pressure has also been reported to be a risk factor for WMLs. However, also other pathogenetic mechanisms may be involved. Hypertension may cause disturbances in the blood-brain barrier, which may cause lesions in the white matter by cerebral oedema, by activation of astrocytes or by destructive enzymes or other poisons which pass through the damaged vessel walls. The renin-angiotensin system is an example of a system that may be involved in the pathogenesis of both hypertension and arteriosclerosis. Its effector peptide angiotensin II has several blood-pressure-increasing effects, such as direct vasoconstriction and activation of the sympathetic nervous system. It also promotes hyperplasia and hypertrophy in vascular smooth muscle cells. Recently an association between hypertension and Alzheimer’s disease has been reported. It is not clear whether this may be the reason for the common occurrence of WMLs in cases of late-onset Alzheimer’s disease, as Alzheimer’s disease may also cause lesions in the cerebral microvasculature. The association between WMLs and hypertension may thus be mediated through several different pathogenetic pathways.
- 1 July 1998
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 9 (Suppl. 1) , 13-19
A Review on Blood Pressure and Ischaemic White Matter Lesions
Hypertension or high blood pressure is constantly reported to be the main risk factors for ischaemic white matter lesions (WMLs). These lesions show the histopathological picture of diffuse demyelination and moderate loss of axons in subcortical structures. The main hypothesis regarding the association between high blood pressure and ischaemic WMLs is that long-standing hypertension causes lipohyalinosis of the media and thickening of the vessel walls with narrowing of the lumen of the small perforating arteries and arterioles which nourish the deep white matter. Episodes of hypotension may then lead to hypoperfusion and hypoxia-ischaemia in the white matter. In line with this, low blood pressure has also been reported to be a risk factor for WMLs. However, also other pathogenetic mechanisms may be involved. Hypertension may cause disturbances in the blood-brain barrier, which may cause lesions in the white matter by cerebral oedema, by activation of astrocytes or by destructive enzymes or other poisons which pass through the damaged vessel walls. The renin-angiotensin system is an example of a system that may be involved in the pathogenesis of both hypertension and arteriosclerosis. Its effector peptide angiotensin II has several blood-pressure-increasing effects, such as direct vasoconstriction and activation of the sympathetic nervous system. It also promotes hyperplasia and hypertrophy in vascular smooth muscle cells. Recently an association between hypertension and Alzheimer’s disease has been reported. It is not clear whether this may be the reason for the common occurrence of WMLs in cases of late-onset Alzheimer’s disease, as Alzheimer’s disease may also cause lesions in the cerebral microvasculature. The association between WMLs and hypertension may thus be mediated through several different pathogenetic pathways.
- 1 February 1998
- Published by S. Karger AG in Neuroepidemiology
- Vol. 17 (1) , 2-9
Status of Risk Factors for Vascular Dementia
The two most common causes of vascular dementia (VAD) are dementia evolving in connection with multiple small or large strokes and dementia related to ischemic white-matter lesions (WMLs) of the brain. The knowledge about risk factors for these disorders is still scarce. Besides sharing risk factors with stroke, dementia with multiple small or large brain infarcts is also associated with non-vascular risk factors such as high alcohol consumption, psychological stress in early life, lower formal education, blue collar occupation, and occupational exposures. Risk factors for dementia in stroke victims include stroke-related and non-stroke related risk factors. Non-stroke-related factors are similar to those found in Alzheimer’s disease. The main risk factors for ischemic WMLs are hypertension or increased blood pressure, but WMLs have also been associated with a number of other vascular risk factors. In recent years, Alzheimer’s disease (AD) has also been reported to be associated with vascular risk factors, including hypertension, coronary heart disease, atrial fibrillation, diabetes mellitus, and WMLs. Although these associations may reflect an overdiagnosis of AD in cases with silent cerebrovascular disease, or that cerebrovascular disease increases the possibility that individuals with Alzheimer lesions will express a dementia syndrome, there are also alternative explanations. AD and cerebrovascular disease may for instance share similar risk factors or etiologic pathways. The pathogenetic implications for the association between AD and vascular factors need to be further explored. There is also a need for more studies on risk factors for VAD and risk factors for dementia in stroke samples, as well as studies on non-vascular risk factors for ischemic WMLs.
- 1 February 1998
- Published by S. Karger AG in Neuroepidemiology
- Vol. 17 (1) , 2-9
Status of Risk Factors for Vascular Dementia
The two most common causes of vascular dementia (VAD) are dementia evolving in connection with multiple small or large strokes and dementia related to ischemic white-matter lesions (WMLs) of the brain. The knowledge about risk factors for these disorders is still scarce. Besides sharing risk factors with stroke, dementia with multiple small or large brain infarcts is also associated with non-vascular risk factors such as high alcohol consumption, psychological stress in early life, lower formal education, blue collar occupation, and occupational exposures. Risk factors for dementia in stroke victims include stroke-related and non-stroke related risk factors. Non-stroke-related factors are similar to those found in Alzheimer’s disease. The main risk factors for ischemic WMLs are hypertension or increased blood pressure, but WMLs have also been associated with a number of other vascular risk factors. In recent years, Alzheimer’s disease (AD) has also been reported to be associated with vascular risk factors, including hypertension, coronary heart disease, atrial fibrillation, diabetes mellitus, and WMLs. Although these associations may reflect an overdiagnosis of AD in cases with silent cerebrovascular disease, or that cerebrovascular disease increases the possibility that individuals with Alzheimer lesions will express a dementia syndrome, there are also alternative explanations. AD and cerebrovascular disease may for instance share similar risk factors or etiologic pathways. The pathogenetic implications for the association between AD and vascular factors need to be further explored. There is also a need for more studies on risk factors for VAD and risk factors for dementia in stroke samples, as well as studies on non-vascular risk factors for ischemic WMLs.
- Open Access
- 1 January 1998
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 64 (1) , 37-43
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
OBJECTIVES To study the association of apoE genotypes with dementia and cerebrovascular disorders in a population based sample of 85 year old people. METHODS A representative sample of 85 year old people (303 non-demented, 109 demented) were given a neuropsychiatric and a medical examination and head CT. The apoE isoforms were determined. Dementia was diagnosed according to DSM-III-R. RESULTS At the age of 85, carriers of the apoE ε4 allele had an increased odds ratio (OR) for dementia (1.9; pCONCLUSIONS Neither the apoE ε4 allele nor white matter lesions are sufficient risk factors by themselves for dementia at very old ages, whereas possession of both these entities increases the risk for Alzheimer’s disease and vascular dementia substantially.
- 1 January 1998
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 64 (1) , 37-43
Open AccessA population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
OBJECTIVES To study the association of apoE genotypes with dementia and cerebrovascular disorders in a population based sample of 85 year old people. METHODS A representative sample of 85 year old people (303 non-demented, 109 demented) were given a neuropsychiatric and a medical examination and head CT. The apoE isoforms were determined. Dementia was diagnosed according to DSM-III-R. RESULTS At the age of 85, carriers of the apoE ε4 allele had an increased odds ratio (OR) for dementia (1.9; pCONCLUSIONS Neither the apoE ε4 allele nor white matter lesions are sufficient risk factors by themselves for dementia at very old ages, whereas possession of both these entities increases the risk for Alzheimer’s disease and vascular dementia substantially.
- 1 August 1996
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 153 (8) , 1015-1020
Suicidal feelings in a population sample of nondemented 85-year-olds
The authors studied the 1-month frequency of suicidal feelings among very old people. A population sample (N = 345) of nondemented 85-year-olds in Gothenburg, Sweden, were examined by a psychiatrist. Suicidal feelings were rated by the system of Paykel et al. Mental disorders were diagnosed according to DSM-III-R. Of the mentally healthy subjects (N = 225), 4.0% had thought during the last month that life was not worth living, 4.0% had had death wishes, and 0.9% had thought of taking their own lives. None had seriously considered suicide. The figures were higher among subjects with mental disorders (N = 120); 29.2% had thought that life was not worth living, 27.5% had had death wishes, 9.2% had thought about taking their lives, and 1.7% had seriously considered suicide. Among the subjects with mental disorders, including depression, suicidal feelings were associated with greater use of anxiolytics but not of antidepressants. Women who felt that life was not worth living had a higher 3-year mortality rate than did women without these feelings (43.2% versus 14.2%). This finding was independent of concomitant physical and mental disorders. Mild suicidal feelings are common in elderly subjects with metal disorders but infrequent in the mentally healthy. The substantially higher mortality rate in women who felt that life was not worth living, compared to women who did not, suggests these feelings must be taken seriously. Because of the high suicide rate in the elderly, there is a need for better diagnosis and treatment of mental disorders in this age group.
- 1 August 1996
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 153 (8) , 1015-1020
Suicidal feelings in a population sample of nondemented 85-year-olds
The authors studied the 1-month frequency of suicidal feelings among very old people. A population sample (N = 345) of nondemented 85-year-olds in Gothenburg, Sweden, were examined by a psychiatrist. Suicidal feelings were rated by the system of Paykel et al. Mental disorders were diagnosed according to DSM-III-R. Of the mentally healthy subjects (N = 225), 4.0% had thought during the last month that life was not worth living, 4.0% had had death wishes, and 0.9% had thought of taking their own lives. None had seriously considered suicide. The figures were higher among subjects with mental disorders (N = 120); 29.2% had thought that life was not worth living, 27.5% had had death wishes, 9.2% had thought about taking their lives, and 1.7% had seriously considered suicide. Among the subjects with mental disorders, including depression, suicidal feelings were associated with greater use of anxiolytics but not of antidepressants. Women who felt that life was not worth living had a higher 3-year mortality rate than did women without these feelings (43.2% versus 14.2%). This finding was independent of concomitant physical and mental disorders. Mild suicidal feelings are common in elderly subjects with metal disorders but infrequent in the mentally healthy. The substantially higher mortality rate in women who felt that life was not worth living, compared to women who did not, suggests these feelings must be taken seriously. Because of the high suicide rate in the elderly, there is a need for better diagnosis and treatment of mental disorders in this age group.